Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
63
Number of overlapping holdings
100.0%
% of XLV's 64 holdings also in FHLC
17.6%
% of FHLC's 372 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FHLC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.2% | 10.2% | 10.2% |
|
UNITEDHEALTH GROUP INC | 9.0% | 7.3% | 7.3% |
|
JOHNSON & JOHNSON | 6.9% | 6.3% | 6.3% |
|
MERCK & CO. INC. | 6.2% | 5.2% | 5.2% |
|
ABBVIE INC | 5.7% | 5.1% | 5.1% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FHLC
|
UNITEDHEALTH GROUP INC | 1.7% |
|
ELI LILLY & CO | 1.0% |
|
MERCK & CO. INC. | 1.0% |
|
JOHNSON & JOHNSON | 0.6% |
|
ABBVIE INC | 0.6% |
|
ELEVANCE HEALTH INC | 0.5% |
|
THERMO FISHER SCIENTIFIC INC | 0.5% |
|
PFIZER INC | 0.4% |
|
CIGNA CORPORATION | 0.4% |
|
AMGEN INC | 0.4% |
XLV Underweight Relative to FHLC
|
VEEVA SYSTEMS INC-CLASS A | -0.5% |
|
ALNYLAM PHARMACEUTICALS INC | -0.3% |
|
AVANTOR, INC. | -0.3% |
|
BIOMARIN PHARMACEUTICAL INC | -0.3% |
|
NEUROCRINE BIOSCIENCES INC | -0.2% |
|
ROYALTY PHARMA PLC CLASS A | -0.2% |
|
UNITED THERAPEUTICS CORP | -0.2% |
|
EXACT SCIENCES CORP | -0.2% |
|
REPLIGEN CORP | -0.2% |
|
SAREPTA THERAPEUTICS INC | -0.2% |